$SANM
SANMINA CORP

2012 Q3 Form 10-Q Financial Statement

#000089772312000023 Filed on July 31, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2012 Q2 2011 Q3
Revenue $1.579B $1.549B $1.674B
YoY Change -5.71% -1.26% 3.02%
Cost Of Revenue $1.463B $1.444B $1.543B
YoY Change -5.13% -0.56% 2.76%
Gross Profit $115.2M $105.3M $131.6M
YoY Change -12.46% -9.91% 6.04%
Gross Profit Margin 7.3% 6.79% 7.86%
Selling, General & Admin $57.80M $60.97M $67.04M
YoY Change -13.79% -2.0% 2.51%
% of Gross Profit 50.17% 57.92% 50.94%
Research & Development $6.300M $5.587M $5.797M
YoY Change 8.68% 13.7% 87.0%
% of Gross Profit 5.47% 5.31% 4.4%
Depreciation & Amortization $24.40M $24.60M $25.40M
YoY Change -3.94% -1.2% 15.98%
% of Gross Profit 21.18% 23.37% 19.3%
Operating Expenses $64.80M $69.86M $78.69M
YoY Change -17.66% -3.24% 13.56%
Operating Profit $50.40M $35.39M $52.91M
YoY Change -4.74% -20.7% -3.45%
Interest Expense -$8.900M $16.13M $24.84M
YoY Change -135.82% -38.59% -185.96%
% of Operating Profit -17.66% 45.58% 46.96%
Other Income/Expense, Net -$8.100M -$22.60M -$39.25M
YoY Change -79.37% -4.44% -13184.67%
Pretax Income $15.10M $12.80M $13.65M
YoY Change 10.6% -39.03% -58.75%
Income Tax -$149.0M $3.849M $4.248M
% Of Pretax Income -986.75% 30.08% 31.11%
Net Earnings $164.2M $8.948M $9.405M
YoY Change 1645.88% -31.51% -56.46%
Net Earnings / Revenue 10.4% 0.58% 0.56%
Basic Earnings Per Share $0.11 $0.12
Diluted Earnings Per Share $1.964M $0.11 $0.11
COMMON SHARES
Basic Shares Outstanding 81.58M shares 81.52M shares 80.58M shares
Diluted Shares Outstanding 83.57M shares 83.14M shares

Balance Sheet

Concept 2012 Q3 2012 Q2 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $410.0M $395.0M $583.0M
YoY Change -29.67% -39.69% -12.33%
Cash & Equivalents $409.6M $394.9M $582.8M
Short-Term Investments
Other Short-Term Assets $88.00M $96.00M $125.0M
YoY Change -29.6% -29.41% -10.71%
Inventory $826.5M $826.7M $886.0M
Prepaid Expenses
Receivables $1.002B $1.017B $1.042B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.326B $2.335B $2.636B
YoY Change -11.75% -9.36% 2.01%
LONG-TERM ASSETS
Property, Plant & Equipment $569.4M $566.3M $563.0M
YoY Change 1.13% 0.91% 0.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $272.1M $131.7M $118.0M
YoY Change 130.61% 4.94% 2.61%
Total Long-Term Assets $841.5M $698.0M $681.0M
YoY Change 23.57% 1.64% 0.59%
TOTAL ASSETS
Total Short-Term Assets $2.326B $2.335B $2.636B
Total Long-Term Assets $841.5M $698.0M $681.0M
Total Assets $3.168B $3.033B $3.317B
YoY Change -4.5% -7.04% 1.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $937.7M $895.9M $958.0M
YoY Change -2.12% 4.86% 0.21%
Accrued Expenses $222.0M $232.0M $260.0M
YoY Change -14.62% -0.85% -2.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $60.00M $30.00M $60.00M
YoY Change 0.0% -51.61% 17.65%
Total Short-Term Liabilities $1.220B $1.157B $1.279B
YoY Change -4.65% 0.65% 0.39%
LONG-TERM LIABILITIES
Long-Term Debt $837.4M $940.0M $1.152B
YoY Change -27.31% -24.19% -7.17%
Other Long-Term Liabilities $147.1M $129.7M $137.0M
YoY Change 7.37% -8.42% 12.3%
Total Long-Term Liabilities $984.5M $1.070B $1.289B
YoY Change -23.63% -22.57% -5.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.220B $1.157B $1.279B
Total Long-Term Liabilities $984.5M $1.070B $1.289B
Total Liabilities $2.204B $2.227B $2.567B
YoY Change -14.14% -12.02% -2.65%
SHAREHOLDERS EQUITY
Retained Earnings -$4.961B
YoY Change
Common Stock $6.075B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $214.1M
YoY Change
Treasury Stock Shares 13.34M shares
Shareholders Equity $963.8M $805.8M $749.0M
YoY Change
Total Liabilities & Shareholders Equity $3.168B $3.033B $3.317B
YoY Change -4.5% -7.04% 1.72%

Cashflow Statement

Concept 2012 Q3 2012 Q2 2011 Q3
OPERATING ACTIVITIES
Net Income $164.2M $8.948M $9.405M
YoY Change 1645.88% -31.51% -56.46%
Depreciation, Depletion And Amortization $24.40M $24.60M $25.40M
YoY Change -3.94% -1.2% 15.98%
Cash From Operating Activities $121.1M $47.60M $51.40M
YoY Change 135.6% -55.43% -303.97%
INVESTING ACTIVITIES
Capital Expenditures -$22.50M -$15.40M -$28.00M
YoY Change -19.64% -28.7% 233.33%
Acquisitions
YoY Change
Other Investing Activities $1.600M -$1.500M $9.300M
YoY Change -82.8% -148.39% -47.16%
Cash From Investing Activities -$20.90M -$16.90M -$18.80M
YoY Change 11.17% -7.65% -304.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -83.50M -101.6M -105.1M
YoY Change -20.55% -547.58% -2121.15%
NET CHANGE
Cash From Operating Activities 121.1M 47.60M 51.40M
Cash From Investing Activities -20.90M -16.90M -18.80M
Cash From Financing Activities -83.50M -101.6M -105.1M
Net Change In Cash 16.70M -70.90M -72.50M
YoY Change -123.03% -163.76% 571.3%
FREE CASH FLOW
Cash From Operating Activities $121.1M $47.60M $51.40M
Capital Expenditures -$22.50M -$15.40M -$28.00M
Free Cash Flow $143.6M $63.00M $79.40M
YoY Change 80.86% -50.93% -572.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
895859000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
984014000 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1017355000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1014121000 USD
CY2011Q4 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
8542000 USD
CY2012Q2 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
1857000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-24199000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-31984000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
7792000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
7541000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
106764000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
110263000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74773000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
70738000 USD
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11807000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14537000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2395000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
672000 USD
CY2011Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
958000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2875000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6467000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9211000 shares
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7621000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8219000 shares
CY2012Q2 us-gaap Assets
Assets
3032921000 USD
CY2011Q4 us-gaap Assets
Assets
3353973000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
2629246000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
2334895000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
640288000 USD
us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
3465000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4225000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394862000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
582816000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
592812000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
52555000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
8704000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-245426000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9996000 USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16900000 shares
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20119000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8228000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
68580000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10052000 USD
CY2011Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1542599000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4194125000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4529230000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1444050000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1945000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1254000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
1900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75368000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75074000 USD
us-gaap Derivative Credit Risk
DerivativeCreditRisk
not material
CY2011 us-gaap Derivative Credit Risk
DerivativeCreditRisk
not material
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-8704000 USD
CY2011Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-2799000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-9455000 USD
CY2012Q2 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1562000 USD
CY2012Q2 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
1231000 USD
CY2011Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-4053000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-1670000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-1180000 USD
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
594000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1753000 USD
CY2012Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
115070000 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
112193000 USD
CY2011Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
8302000 USD
CY2012Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
1736000 USD
CY2011Q3 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
1440000 USD
CY2012Q2 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
1298000 USD
us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
1298000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3465000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1744000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16098000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10697000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
105252000 USD
us-gaap Gross Profit
GrossProfit
320625000 USD
us-gaap Gross Profit
GrossProfit
376479000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
131601000 USD
CY2011Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2012Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2077000 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
85000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12797000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70724000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34830000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13653000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19895000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4248000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18746000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3849000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7860000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10376000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-81156000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
42109000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19949000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3342000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-62035000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39238000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15709000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15524000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
16139000 USD
CY2012Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
580593000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
24843000 USD
us-gaap Interest Expense
InterestExpense
77773000 USD
CY2011Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
98097000 USD
CY2012Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
98244000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1095000 USD
us-gaap Interest Expense
InterestExpense
58361000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
16131000 USD
us-gaap Interest Paid
InterestPaid
51563000 USD
us-gaap Interest Paid
InterestPaid
63257000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
369000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4145000 USD
CY2012Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
147888000 USD
CY2011Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
151310000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
891325000 USD
CY2012Q2 us-gaap Inventory Net
InventoryNet
826725000 USD
CY2011Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
641918000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1490000 USD
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
356000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3032921000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3353973000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1157454000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1265885000 USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1317571000 USD
CY2012Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1069715000 USD
CY2012Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
895300000 USD
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
940016000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1182308000 USD
CY2011Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
18900000 USD
CY2012Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
18700000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-283280000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-90401000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73703000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57082000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
155861000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94342000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
9405000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
8948000 USD
us-gaap Net Income Loss
NetIncomeLoss
16084000 USD
us-gaap Net Income Loss
NetIncomeLoss
50829000 USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-39254000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22597000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70460000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-87772000 USD
us-gaap Operating Expenses
OperatingExpenses
217983000 USD
us-gaap Operating Expenses
OperatingExpenses
215335000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
69858000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
78694000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
105290000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
35394000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
158496000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
52907000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
2077000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
85000 USD
CY2011Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
24898000 USD
CY2012Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
32606000 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
131687000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
136630000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3499000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3317000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10268000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1915000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
7524000 USD
CY2011Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1254000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2793000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
7785000 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
109478000 USD
CY2012Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
116525000 USD
CY2011Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
33211000 USD
CY2012Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
25326000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
135263000 USD
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
129699000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-165000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
152000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11489000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14767000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6835000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13194000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
256770000 USD
CY2011Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
60200000 USD
CY2012Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
30000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
10970000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2685000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5719000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14656000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56076000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82800000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
83512000 USD
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
95953000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1995000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
500000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
178000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
11567000 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
4380000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4713000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23753000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
44000000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
44900000 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
566339000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
588097000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1303000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
65000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
178000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
590623000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
49500000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
74200000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5587000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15643000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14877000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5797000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
822000 USD
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1674200000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
4905709000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1549302000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
4514750000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.42
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.67
sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.491
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
183046000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187726000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60965000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67043000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14894000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13120000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4527000 USD
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6970000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
5000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
610000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
175000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.44
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.20
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.69
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2213000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2302000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1838000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2287000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.59
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.61
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y6M18D
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y3M26D
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y9M15D
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y7M17D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.850
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.860
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.857
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.906
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2900000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7626000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.50
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
116000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
892000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
753000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.45
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.56
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.87
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
31022000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16839000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10265000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14195000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10922000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11242000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11606000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11737000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.35
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.46
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.64
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.85
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
9673000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10857000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
13.67
CY2011Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.64
CY2012Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.58
CY2012Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.99
CY2011Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y0M0D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y0M0D
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y0M0D
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7501000 USD
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M10D
CY2011Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M28D
CY2011Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M21D
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2012Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M21D
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y6M0D
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
15672000 USD
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83141000 shares
CY2010Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
17752000 USD
CY2012Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
15431000 USD
CY2011Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
16501000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8652000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6785000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
7401000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6544000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
770517000 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
805752000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83275000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83469000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83566000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80223000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81213000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81519000 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80579000 shares
CY2011Q4 sanm Assets And Liabilities Associated With Deferred Compensation Measured At Fair Value On Recurring Basis
AssetsAndLiabilitiesAssociatedWithDeferredCompensationMeasuredAtFairValueOnRecurringBasis
10000000 USD
CY2012Q2 sanm Assets And Liabilities Associated With Deferred Compensation Measured At Fair Value On Recurring Basis
AssetsAndLiabilitiesAssociatedWithDeferredCompensationMeasuredAtFairValueOnRecurringBasis
9000000 USD
CY2012Q2 sanm Long Term Debt At Carrying Value
LongTermDebtAtCarryingValue
907400000 USD
CY2011Q3 sanm Minimum Pension Liability
MinimumPensionLiability
14000 USD
CY2012Q2 sanm Minimum Pension Liability
MinimumPensionLiability
196000 USD
sanm Minimum Pension Liability
MinimumPensionLiability
41000 USD
sanm Minimum Pension Liability
MinimumPensionLiability
251000 USD
sanm Number Of Customers Representing10 Or More Of Net Sales
NumberOfCustomersRepresenting10OrMoreOfNetSales
1
sanm Number Of Customers Representing10 Or More Of Net Sales
NumberOfCustomersRepresenting10OrMoreOfNetSales
1
CY2012Q2 sanm Number Of Customers Representing10 Or More Of Net Sales
NumberOfCustomersRepresenting10OrMoreOfNetSales
2
CY2011Q3 sanm Number Of Customers Representing10 Or More Of Net Sales
NumberOfCustomersRepresenting10OrMoreOfNetSales
1
sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.492
CY2011Q3 sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.502
CY2012Q2 sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.508
sanm Restructuring And Integration Costs
RestructuringAndIntegrationCosts
13472000 USD
CY2011Q3 sanm Restructuring And Integration Costs
RestructuringAndIntegrationCosts
6336000 USD
sanm Restructuring And Integration Costs
RestructuringAndIntegrationCosts
15885000 USD
CY2012Q2 sanm Restructuring And Integration Costs
RestructuringAndIntegrationCosts
3932000 USD
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestNumber
1830000 shares
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestWeightedAverageGrantDateFairValue
10.59
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestWeightedAverageRemainingContractualTerm
P1Y3M26D
CY2011Q4 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
235000 shares
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
20000 shares
CY2012Q1 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
86000 shares
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cancellations Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCancellationsForfeituresAndExpirationsInPeriod
258000 shares
CY2011Q4 sanm Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cancellations Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCancellationsForfeituresAndExpirationsInPeriod
208000 shares
CY2012Q1 sanm Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cancellations Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCancellationsForfeituresAndExpirationsInPeriod
480000 shares
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cancellations Forfeitures And Expirations Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCancellationsForfeituresAndExpirationsWeightedAverageExercisePrice
17.96
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-29
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2012Q1 sanm Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cancellations Forfeitures And Expirations Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCancellationsForfeituresAndExpirationsWeightedAverageExercisePrice
8.76
CY2011Q4 sanm Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cancellations Forfeitures And Expirations Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCancellationsForfeituresAndExpirationsWeightedAverageExercisePrice
12.88
CY2012Q2 sanm Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Nonvested And Expected To Vest Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNonvestedAndExpectedToVestAggregateIntrinsicValue
13176000 USD
CY2012Q1 sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
13.84
CY2011Q4 sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
11.39
CY2012Q2 sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
12.07
CY2011Q4 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
14249000 USD
CY2012Q2 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
16470000 USD
CY2011Q4 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
19119000 USD
CY2012Q1 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
26519000 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000897723
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81575100 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SANMINA-SCI CORP
dei Entity Voluntary Filers
EntityVoluntaryFilers
No

Files In Submission

Name View Source Status
0000897723-12-000023-index-headers.html Edgar Link pending
0000897723-12-000023-index.html Edgar Link pending
0000897723-12-000023.txt Edgar Link pending
0000897723-12-000023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sanm-20120630.xml Edgar Link completed
sanm-20120630.xsd Edgar Link pending
sanm-20120630_cal.xml Edgar Link unprocessable
sanm-20120630_def.xml Edgar Link unprocessable
sanm-20120630_lab.xml Edgar Link unprocessable
sanm-20120630_pre.xml Edgar Link unprocessable
sanmina-sci_ex311x20120630.htm Edgar Link pending
sanmina-sci_ex312x20120630.htm Edgar Link pending
sanmina-sci_ex321x20120630.htm Edgar Link pending
sanmina-sci_ex322x20120630.htm Edgar Link pending
sanmina-sci_june302012x10xq.htm Edgar Link pending
Show.js Edgar Link pending